Today: 10 June 2026
Gold price hits three-week high as Trump tariff deadline nears; Fed and data next
23 February 2026
1 min read

Gold price hits three-week high as Trump tariff deadline nears; Fed and data next

New York, February 23, 2026, 16:23 EST — After-hours

Gold jumped over 2% Monday, climbing to a three-week high as investors moved into bullion on renewed tariff worries and a weaker dollar.
By 1:33 p.m. ET, spot gold had gained 2% to $5,206.39 an ounce, while April U.S. gold futures finished up 2.8% at $5,225.60. Earlier, the metal hit a record $5,594.82 on Jan. 29. Silver surged 3.2% to $87.23. Platinum dropped 0.7% to $2,140.75, and palladium edged up 0.1% to $1,750.53. “Our expectation is that gold prices could rise sharply this week once activity picks up,” said Jeffrey Christian, managing partner at CPM Group, pointing to mainland China’s reopening on Tuesday after the Lunar New Year holiday. Reuters

Policy risk has stopped being just a talking point; it’s now real. The U.S. Supreme Court threw out President Donald Trump’s emergency tariffs, prompting Trump to roll out a new temporary import tariff through a different statute—leaving traders scrambling to figure out potential carve-outs and the overall reach. The fresh 15% levy kicks in at 12:01 a.m. EST on Tuesday. U.S. Customs and Border Protection, for its part, will halt collection of the struck-down tariffs at that same moment.

Tariffs are about rates just as much as they’re about trade for markets. Slap a broad import levy on, and inflation shifts—growth, too. That ricochets into the dollar, shaping how investors think about the Fed’s next move.

Gold carries the “safe-haven” label, drawing buyers when nerves set in. The metal usually outperforms in low-rate environments, since bullion itself doesn’t offer any yield.

There was a defensive edge to Monday’s surge. Gold tends to be the go-to hedge when stocks jolt and headlines get volatile.

Fresh commentary from the Fed is circulating. Federal Reserve Governor Christopher Waller signaled he’s willing to keep rates steady at the next March meeting, depending on whether February’s jobs data indicate a stronger labor market. That February employment report lands March 6, just before the Fed gathers March 17-18.

Gold’s moves at these levels can be abrupt. Should tariffs face a delay, get trimmed, or exemptions kick in, that safe-haven premium could vanish as swiftly as it appeared.

A stronger dollar would hit as well. Gold gets pricier for euro, yen, or yuan buyers when the greenback climbs—even if the metal’s price barely budges in dollar terms.

Tuesday brings the U.S. consumer confidence reading at 10 a.m. ET—a quick pulse-check for traders watching jobs and spending trends. Over in bonds: Treasury auctions kick off with 2-year notes Tuesday, 5-years hitting the block Wednesday, and 7-years set for Thursday. These can nudge yields, which in turn shape the case for bullion.

Stock Market Today

  • Copart (CPRT) Share Price Slump Raises Reassessment Questions Amid Undervaluation
    June 10, 2026, 8:50 AM EDT. Copart's share price has declined 37.7% over the past year, prompting investors to reassess its value. Recent trading closed at $31.31, a 1.5% rise over seven days but down 17.1% year to date. A Discounted Cash Flow (DCF) analysis estimates Copart's intrinsic value at $38.93, suggesting the stock is undervalued by approximately 19.6%. The DCF model, focusing on future free cash flow projections, indicates potential upside if cash flow assumptions hold. Copart trades at a Price-to-Earnings (P/E) ratio of 18.66, reflecting investor expectations on growth and risk. The prolonged multi-year price slump, coupled with evolving market perceptions in vehicle auction and salvage sectors, is driving fresh investor scrutiny on Copart's risk and growth potential.

Latest articles

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
IREN Stock Pauses as Nvidia Rally Cools Before Holiday

IREN Shares Fall Again; Microsoft AI Cloud Agreement Still in Focus

10 June 2026
IREN plunged 8.73% to $54.02 Tuesday and slid another 3.72% premarket as investors weighed Wall Street’s bullish calls on its AI cloud buildout against a tech and crypto selloff; the stock’s fate now hinges on IREN’s ability to deliver Microsoft- and Nvidia-linked AI infrastructure on schedule, with the Microsoft contract at risk if timelines slip.
Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Previous Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

National Grid share price ticks up as Ofgem flags AI data-centre power crunch
Next Story

National Grid share price ticks up as Ofgem flags AI data-centre power crunch

Go toTop